We are live on
!
Find out more
DCM
DAFNA Capital Management Portfolio holdings
AUM
$440M
1-Year Est. Return
109.12%
This Fund
S&P 500
This Quarter
Est. Return
+13.31%
1 Year Est. Return
+109.12%
3 Year Est. Return
+239.59%
5 Year Est. Return
+227.89%
10 Year Est. Return
+3,611.91%
AUM
$118M
AUM Growth
+$4.41M
(+3.9%)
Cap. Flow
-$8.19M
Cap. Flow
% of AUM
-6.92%
Top 10 Holdings %
Top 10 Hldgs %
44.84%
Holding
84
New
17
Increased
12
Reduced
22
Closed
11
Top Buys
| 1 |
LOXO
Loxo Oncology, Inc
LOXO
|
+$6.63M |
| 2 |
BioCryst Pharmaceuticals
BCRX
|
+$3.31M |
| 3 |
CLLS
Cellectis
CLLS
|
+$1.61M |
| 4 |
Rigel Pharmaceuticals
RIGL
|
+$1.21M |
| 5 |
BLRX
BioLineRX
BLRX
|
+$1.07M |
Top Sells
| 1 |
Cytokinetics
CYTK
|
+$2.56M |
| 2 |
AERI
Aerie Pharmaceuticals
AERI
|
+$2.3M |
| 3 |
DERM
Dermira, Inc.
DERM
|
+$2.28M |
| 4 |
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
|
+$2.21M |
| 5 |
TSRO
TESARO, Inc.
TSRO
|
+$2.08M |
Sector Composition
| 1 | Healthcare | 85.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LOXO
1
DELISTED
Loxo Oncology, Inc
LOXO
| $12.7M | 10.7% |
300,722
+161,000
| +115% | +$6.63M |
|
2
AtriCure
ATRC
$1.75B
| $9.71M | 8.21% |
506,946
-12,000
| -2% | -$210K |
|
|
NXTM
3
DELISTED
NxStage Medical Inc.
NXTM
| $5.8M | 4.9% |
216,119
-20,000
| -8% | -$552K |
|
|
ALDR
4
DELISTED
Alder Biopharmaceuticals
ALDR
| $4.6M | 3.89% |
221,013
| – | – |
|
|
5
BioCryst Pharmaceuticals
BCRX
$2.4B
| $4.54M | 3.84% |
541,128
+475,228
| +721% | +$3.31M |
|
|
VIRX
6
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $3.56M | 3.01% |
24,787
-7,601
| -23% | -$1.09M |
|
|
BPMC
7
DELISTED
Blueprint Medicines
BPMC
| $3.3M | 2.79% |
82,500
+10,000
| +14% | +$358K |
|
|
LKFT
8
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.94B
| $3.05M | 2.58% |
35,359
-30,709
| -46% | -$2.21M |
|
|
ONC
9
BeOne Medicines Ltd
ONC
$32.2B
| $2.97M | 2.52% |
81,231
-38,610
| -32% | -$1.41M |
|
|
AGTC
10
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $2.84M | 2.4% |
411,000
+124,702
| +44% | +$974K |
|
11
Ardelyx
ARDX
$1.3B
| $2.81M | 2.37% |
221,738
+47,743
| +27% | +$628K |
|
12
Insulet
PODD
$11B
| $2.74M | 2.31% |
63,484
-10,000
| -14% | -$429K |
|
13
Spyre Therapeutics
SYRE
$8.84B
| $2.61M | 2.21% |
14,016
| – | – |
|
14
iShares Biotechnology ETF
IBB
$9.22B
| $2.55M | 2.16% |
26,100
| – | – |
|
15
Neurocrine Biosciences
NBIX
$17.2B
| $2.53M | 2.14% |
58,508
-7,500
| -11% | -$321K |
|
16
MacroGenics
MGNX
$270M
| $2.22M | 1.88% |
119,200
+30,000
| +34% | +$579K |
|
|
BEAT
17
DELISTED
BioTelemetry, Inc.
BEAT
| $2.17M | 1.84% |
75,000
| – | – |
|
|
AERI
18
DELISTED
Aerie Pharmaceuticals
AERI
| $2.12M | 1.79% |
46,770
-51,600
| -52% | -$2.3M |
|
|
SPNC
19
DELISTED
Spectranetics Corp
SPNC
| $1.91M | 1.61% |
65,496
| – | – |
|
|
RDUS
20
DELISTED
Radius Health, Inc.
RDUS
| $1.89M | 1.6% |
48,809
-5,045
| -9% | -$212K |
|
|
CLLS
21
Cellectis
CLLS
$281M
| $1.83M | 1.55% |
+76,404
| New | +$1.61M |
|
|
TVRD
22
Tvardi Therapeutics
TVRD
$28.6M
| $1.75M | 1.48% |
2,648
-3,172
| -55% | -$1.69M |
|
|
IMMU
23
DELISTED
Immunomedics Inc
IMMU
| $1.63M | 1.38% |
252,574
-307,100
| -55% | -$1.56M |
|
|
CDTX
24
DELISTED
Cidara Therapeutics
CDTX
| $1.63M | 1.38% |
10,423
+2,427
| +30% | +$426K |
|
|
FOMX
25
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $1.61M | 1.36% |
325,667
+57,600
| +21% | +$554K |
|
Similar funds
FGWP
STCG
SCP
CAAM
AWM
HCM
CPW
DWML